标题：Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma
作者：Shen, Xiaochun; Han, Ye; Xue, Xiaofeng; Li, Wei; Guo, Xiaobo; Li, Pu; Wang, Yunliang; Li, Dechun; Zhou, Jin; Zhi, Qiaoming
作者机构：[Shen, Xiaochun] Soochow Univ, Dept Resp Med, Affiliated Hosp 1, Suzhou 215006, Peoples R China.; [Han, Ye; Xue, Xiaofeng; Wang, Yunliang; Li, Dechu 更多
通讯作者地址：[Zhou, J]Soochow Univ, Dept Gen Surg, Affiliated Hosp 1, Suzhou 215006, Peoples R China.
来源：BIOMEDICINE & PHARMACOTHERAPY
关键词：EGFL7; Invasion; Angiogenesis; Pancreatic carcinoma
摘要：Epidermal growth factor-like domain 7 (EGFL7), also known as vascular endothelial stain, was firstly identified as a modulator of smooth muscle cell migration. Though the expression of EGFL7 was reported to be up-regulated during tumorigenesis, the clinical and biological functions of EGFL7 in pancreatic carcinoma (PC) were still not fully elucidated. In this study, we found that the serum EGFL7 level in PC tissues was statistically higher than that in normal subjects (p < 0.001), and its level in non-resectable patients was also higher than that in resectable ones (p = 0.013). Among these resectable PC patients, the postoperative EGFL7 expression was significantly down-regulated when tumors were resected (p = 0.018). Using the immunohistochemistry method, our results demonstrated that the positive expression of EGFL7 was significantly associated with the TNM stage (p = 0.024), lymph node metastasis (p = 0.003) and local invasion (p = 0.022), and the EGFL7 expression closely correlated to the micro-vessel density (MVD) in PC tissues by Spearman analysis (r = 0.941, p = 0.000). In vitro, EGFL7 was silenced by the small interference RNA in PC cells, and our data indicated that down-regulation of EGFL7 did not influence the cycle progression, proliferation, colony formation and apoptosis of PC cells (p > 0.05), whereas inhibition of EGFL7 expression could decrease PaCa-2 cell invasion (p < 0.05). More interestingly, by tubular formation, Chick embryo chorioallantoic membrane (CAM) and ELISA assays, our results revealed that silencing EGFL7 expression represented a strong inhibiting effect on tubular formation of micro-vessels through down-regulating the protein levels of VEGF and Ang-2 (p < 0.05). Our results raised the possibility of using EGFL7 as a potential prognostic biomarker and therapy target of PC, and down-regulation of EGFL7 might be considered to be a potentially important molecular treatment strategy for patients with PC. (C) 2015 Elsevier Masson SAS. All rights reserved.